Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1983 1
1988 1
1990 1
2005 1
2006 1
2007 1
2009 1
2010 1
2011 3
2012 6
2013 6
2014 6
2015 5
2016 3
2017 6
2018 7
2019 3
2020 8
2021 7
2022 11
2023 10
2024 10
2025 4
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Results by year

Filters applied: . Clear all
Page 1
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial.
Allen JA, Lin J, Basta I, Dysgaard T, Eggers C, Guptill JT, Gwathmey KG, Hewamadduma C, Hofman E, Hussain YM, Kuwabara S, Le Masson G, Leypoldt F, Chang T, Lipowska M, Lowe M, Lauria G, Querol L, Simu MA, Suresh N, Tse A, Ulrichts P, Van Hoorick B, Yamasaki R, Lewis RA, van Doorn PA; ADHERE Study Group. Allen JA, et al. Lancet Neurol. 2024 Oct;23(10):1013-1024. doi: 10.1016/S1474-4422(24)00309-0. Lancet Neurol. 2024. PMID: 39304241 Clinical Trial.
Efficacy, safety and tolerability of rozanolixizumab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a randomised, subject-blind, investigator-blind, placebo-controlled, phase 2a trial and open-label extension study.
Querol L, De Sèze J, Dysgaard T, Levine T, Rao TH, Rivner M, Hartung HP, Kiessling P, Shimizu S, Marmol D, Bozorg A, Colson AO, Massow U, Eftimov F; CIDP01 Study Investigators. Querol L, et al. J Neurol Neurosurg Psychiatry. 2024 Aug 16;95(9):845-854. doi: 10.1136/jnnp-2023-333112. J Neurol Neurosurg Psychiatry. 2024. PMID: 38729747 Free PMC article. Clinical Trial.
Electrodiagnostic subtyping in Guillain-Barré syndrome patients in the International Guillain-Barré Outcome Study.
Arends S, Drenthen J, de Koning L, van den Bergh P, Hadden RDM, Kuwabara S, Reisin RC, Shahrizaila N, Ajroud-Driss S, Antonini G, Attarian S, Balducci C, Bertorini T, Brannagan TH, Cavaletti G, Chao CC, Chavada G, Dillmann KU, Dimachkie MM, Galassi G, Gutiérrez-Gutiérrez G, Harbo T, Islam B, Islam Z, Katzberg H, Kusunoki S, Manganelli F, Miller JAL, Pardo J, Pereon Y, Rajabally YA, Sindrup S, Stettner M, Uncini A, Verhamme C, Vytopil M, Waheed W, Jacobs BC, Cornblath DR; IGOS Consortium. Arends S, et al. Among authors: stettner m. Eur J Neurol. 2024 Sep;31(9):e16335. doi: 10.1111/ene.16335. Epub 2024 Jul 4. Eur J Neurol. 2024. PMID: 38965709 Free PMC article.
Multi-omic identification of perineurial hyperplasia and lipid-associated nerve macrophages in human polyneuropathies.
Heming M, Börsch AL, Wolbert J, Thomas C, Mausberg AK, Szepanowski F, Eggert B, Lu IN, Tietz J, Dienhart F, Meschnark M, Strecker JK, Glatza M, Thomas C, Gmahl N, Dambietz C, Müther M, Uerschels AK, Keyvani K, Minnerup J, Doppler K, Üçeyler N, Aprea J, Dahl A, Stassart R, Fledrich R, Wiendl H, Sommer C, Stettner M, Meyer Zu Hörste G. Heming M, et al. Among authors: stettner m. Nat Commun. 2025 Aug 23;16(1):7872. doi: 10.1038/s41467-025-62964-8. Nat Commun. 2025. PMID: 40849297 Free PMC article.
Preventing long-term disability in CIDP: the role of timely diagnosis and treatment monitoring in a multicenter CIDP cohort.
Quint P, Schroeter CB, Kohle F, Öztürk M, Meisel A, Tamburrino G, Mausberg AK, Szepanowski F, Afzali AM, Fischer K, Nelke C, Räuber S, Voth J, Masanneck L, Willison A, Vogelsang A, Hemmer B, Berthele A, Schroeter M, Hartung HP, Pawlitzki M, Schreiber S, Stettner M, Maus U, Meuth SG, Stascheit F, Ruck T. Quint P, et al. Among authors: stettner m. J Neurol. 2024 Sep;271(9):5930-5943. doi: 10.1007/s00415-024-12548-1. Epub 2024 Jul 11. J Neurol. 2024. PMID: 38990346 Free PMC article.
Extracorporeal therapy procedures (plasma exchange and immunoadsorption) in chronic inflammatory demyelinating polyneuropathies (CIDP)- a database analysis.
Mahlberg M, Dorst J, Elmas Z, Haase U, Heming M, Müller-Miny L, Meyer Zu Hörste G, Stettner M, Then Bergh F, Baum P; Disease-Related Competence Network Peripheral Nervous System (KKPNS). Mahlberg M, et al. Among authors: stettner m. BMC Neurol. 2025 Jul 17;25(1):293. doi: 10.1186/s12883-025-04294-2. BMC Neurol. 2025. PMID: 40676524 Free PMC article.
Respiratory biofeedback and psycho-education for patients with post COVID- 19 symptoms and bodily distress: study protocol of the randomized, controlled explorative intervention trial POSITIV.
Dinse H, Skoda EM, Schweda A, Jansen C, Schmidt K, Konik M, Rohn H, Witzke O, Stettner M, Kleinschnitz C, Bäuerle A, Teufel M. Dinse H, et al. Among authors: stettner m. Trials. 2025 Apr 25;26(1):140. doi: 10.1186/s13063-025-08842-6. Trials. 2025. PMID: 40281597 Free PMC article.
Citalopram suppresses thymocyte cytokine production.
Shenoy AR, Dehmel T, Stettner M, Kremer D, Kieseier BC, Hartung HP, Hofstetter HH. Shenoy AR, et al. Among authors: stettner m. J Neuroimmunol. 2013 Sep 15;262(1-2):46-52. doi: 10.1016/j.jneuroim.2013.06.006. Epub 2013 Jul 22. J Neuroimmunol. 2013. PMID: 23886473
96 results